Tag: Waisman Biomanufacturing
Cynata achieves world-first stem cell manufacturing breakthrough
Australian stem cell and regenerative medicine company Cynata Therapeutics Limited has announced a major stem cell manufacturing milestone that will enable the company to commercialise its...
Cynata Therapeutics partners up with WuXi AppTec for stem cell studies
Cynata Therapeutics, the Australian stem cell and regenerative medicine company that is developing the therapeutic stem cell platform technology Cymerus™, has inked a deal...
Cynata partners with leading biologic product manufacturer
Cynata Therapeutics Ltd has confirmed the signing of an agreement with Waisman Biomanufacturing for manufacturing process development, scale-up and clinical-grade manufacture of its CymerusTM...
Featured Article
Australian Manufacturing Week 2026 enters final run-up to Brisbane debut
Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production.
